New weight-loss jabs may significantly impact the UK economy by helping people return to work, according to Prime Minister Sir Keir Starmer. In a recent interview, Starmer highlighted that anti-obesity medication could not only assist individuals in losing weight but also alleviate some of the pressures faced by the National Health Service (NHS).
The remarks followed Health Secretary Wes Streeting’s suggestion that these weight-loss jabs could be beneficial for unemployed individuals, providing them with a route back into the workforce. Starmer stated, “This drug will be very helpful to people who want to lose weight, need to lose weight, very important for the economy so people can get back into work.” He further emphasized the importance of reducing the pressure on the NHS in conjunction with increasing its funding.
Streeting added that obesity is a significant strain on the health service and on the economy, costing the NHS approximately £11 billion per year. The Health Secretary noted that health issues associated with obesity often lead to increased sick days, disrupting economic productivity.
Plans are underway for real-world trials examining the effectiveness of the anti-obesity drug Mounjaro, also known as tirzepatide, over a five-year period. This research initiative will assess how the drug aids in weight loss, diabetes prevention, and its potential role in reducing work absence due to obesity-related conditions.
In recent studies, Mounjaro has shown promise, with participants losing an average of 21% of their body weight when combined with lifestyle modifications. NHS officials anticipate that nearly 250,000 individuals may receive this jab over the next three years, prioritizing those most likely to benefit.
Data from the Health Survey for England indicates that as of 2022, 29% of adults in England were classified as obese, while 64% were overweight or living with obesity. This public health issue not only burdens the NHS financially, but is also associated with numerous health risks, including type 2 diabetes and various forms of cancer.
As the UK faces rising economic inactivity due to long-term health problems, the importance of addressing obesity is underscored. Health Secretary Streeting insists that individuals must take responsibility for their health, citing that comprehensive support is essential to effectively tackle obesity.
With the potential long-term benefits of these weight-loss jabs, the government hopes to observe a remarkable change in public health and productivity in the workplace, driving both economic recovery and healthier living standards for citizens.
Source: Evening Standard
